clinical trial · NCT04776746
Open-Label Extension Study of Trofinetide for Rett Syndrome
Rett Syndrometrofinetide
brief summary
To investigate the safety and tolerability of continued long-term treatment with oral trofinetide in girls and women with Rett syndrome
started
Nov 8, 2020
primary completion
Jun 30, 2023
completion
Jun 30, 2023
last updated
Sep 27, 2024
official title
An Open-Label Extension Study of Continuing Treatment With Trofinetide for Rett Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol